Physicians Education Resource® Partners with the Florida Society of Clinical Oncology
- Amanda Bridges
- January 26, 2017
- News
PER® and FLASCO to collaborate to develop cancer awareness and provide professional educational opportunities that enhance their missions
(Cranbury NJ, January XX)- Physicians Education Resource®, LLC (PER®), has partnered with the Florida Society of Clinical Oncology, (FLASCO), to continue to promote education to the oncology health care community, announced PER® President Phil Talamo
In making this announcement, Talamo stated, “We are pleased to join in this collaboration agreement with such an important and influential member of Florida’s oncology network. PER® prides itself on providing high-quality, evidence-based education from leading facility members of the oncology health care community, and this agreement will further promote our mission.”
In this partnership, FLASCO will promote PER® conferences through multiple channels in their membership. Each party agrees to display each other’s promotional materials at their events in Florida, as well as FLASCO be named a endorser to be featured on all print and meeting materials. Additionally, FLASCO members will be given a discount to the following PER® conferences:
- 13th Annual International Symposium of Melanoma and Other Cutaneous Malignancies® on February 11th
- 21st Annual International Congress on Hematologic Malignancies® February 23rd-25th
- 34th Annual Miami Breast Conference®, March 9-12th
- 4th Annual Miami Lung Conference®, April 8th
FLASCO consists of over 2,300 of Florida’s medical, radiation, surgical, gynecologic, and pediatric oncologists; oncologists in training; and their physician’s assistants, nurses, nurse practitioners, and other support staff. The state-supported society focuses on providing education, timely disclosure of important information and support to Florida’s oncologists.
About PER®
Since 1995, PER® has been the educational resource of choice for live and online activities focusing on oncology and hematology. PER® provides high-quality, evidence-based activities featuring leading national and international faculty with a focus on practice-changing advances and standards of care in treatment and disease management. Activities also include topics on emerging strategies currently under investigation, supportive care, diagnosis and staging, prevention, screening and early detection, and practice management. With the rapid advances occurring in the field of oncology, understanding how to use molecular data to diagnose and stage patients, selecting the most appropriate candidates for novel therapeutic agents, individualizing treatment based on tumor type, and referring patients to clinical trials will continue to ensure the highest level of patient care is provided. PER® serves the oncology health care community, including physicians, fellows, advanced practice nurses, nurses, physician assistants, pharmacists, and researchers. PER® is part of the Cranbury, N.J.-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com
